BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24100253)

  • 1. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway.
    Chen XQ; Liu X; Wang QX; Zhang MJ; Guo M; Liu F; Jiang WF; Zhou L
    Exp Cell Res; 2015 Jan; 330(1):43-55. PubMed ID: 25152439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.
    Gu J; Hu W; Liu X
    Med Sci Monit Basic Res; 2014 Oct; 20():153-60. PubMed ID: 25296378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.
    Liu C; Liu R; Fu H; Li J; Wang X; Cheng L; Korantzopoulos P; Tse G; Li G; Liu T
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.
    Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
    Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
    Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease.
    Zhang D; Liu X; Chen X; Gu J; Li F; Zhang W; Zheng Y
    Cardiology; 2014; 129(4):216-23. PubMed ID: 25376239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
    Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
    Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
    Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
    J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4.
    Zhang XH; Zheng B; Gu C; Fu JR; Wen JK
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
    Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
    Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
    PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model.
    Xu D; Murakoshi N; Igarashi M; Hirayama A; Ito Y; Seo Y; Tada H; Aonuma K
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):209-17. PubMed ID: 21954843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.